CN104398927A - 治疗膝关节滑膜炎的中药制剂 - Google Patents
治疗膝关节滑膜炎的中药制剂 Download PDFInfo
- Publication number
- CN104398927A CN104398927A CN201410637526.0A CN201410637526A CN104398927A CN 104398927 A CN104398927 A CN 104398927A CN 201410637526 A CN201410637526 A CN 201410637526A CN 104398927 A CN104398927 A CN 104398927A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- mutual
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 24
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 26
- 208000002193 Pain Diseases 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000008961 swelling Effects 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 2
- 230000002787 reinforcement Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000219138 Luffa Species 0.000 abstract 1
- 235000003956 Luffa Nutrition 0.000 abstract 1
- 244000302544 Luffa aegyptiaca Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 241000218164 Menispermaceae Species 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 239000008361 herbal raw material Substances 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 description 21
- 208000006820 Arthralgia Diseases 0.000 description 13
- 210000000629 knee joint Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000003127 knee Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 210000001258 synovial membrane Anatomy 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 241000521257 Hydrops Species 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 201000004595 synovitis Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010023232 Joint swelling Diseases 0.000 description 3
- 229930188824 alisol Natural products 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- IWQURBSTAIRNAE-UHFFFAOYSA-N Alismoxide Chemical compound CC1(O)CCC(C(C)C)=CC2C(O)(C)CCC21 IWQURBSTAIRNAE-UHFFFAOYSA-N 0.000 description 2
- WXHUQVMHWUQNTG-UHFFFAOYSA-N Alisol E 24-acetate Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(OC(C)=O)C(C)(C)O)C)CCC21C WXHUQVMHWUQNTG-UHFFFAOYSA-N 0.000 description 2
- NLOAQXKIIGTTRE-UHFFFAOYSA-N Alisol-B-Monoacetat Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CCC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023215 Joint effusion Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- WXHUQVMHWUQNTG-JSWHPQHOSA-N [(3r,4s,6r)-2,4-dihydroxy-6-[(5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] acetate Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](OC(C)=O)C(C)(C)O)C)CC[C@@]21C WXHUQVMHWUQNTG-JSWHPQHOSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001819 hydrarthrosis Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- -1 n-butene acyl lactone Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- BUPJOLXWQXEJSQ-QLFBSQMISA-N (1r,3as,8as)-1-methyl-4-methylidene-7-propan-2-yl-2,3,3a,5,6,8a-hexahydroazulen-1-ol Chemical compound C=C1CCC(C(C)C)=C[C@@H]2[C@@](O)(C)CC[C@@H]21 BUPJOLXWQXEJSQ-QLFBSQMISA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QXTFJHAHEZDLDP-UHFFFAOYSA-N 16beta-Hydroxyalisol B monoacetate Natural products CC(CC(OC(=O)C)C1OC1(C)C)C2=C3CC(O)C4C5(C)CCC(=O)C(C)(C)C5CCC4(C)C3(C)CC2O QXTFJHAHEZDLDP-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- ZDPDQMCPRXTLIP-PAPYEOQZSA-N Alismoxide Natural products CC(C)C1=C[C@H]2[C@@H](CC[C@]2(C)O)[C@](C)(O)CC1=O ZDPDQMCPRXTLIP-PAPYEOQZSA-N 0.000 description 1
- NLOAQXKIIGTTRE-JSWHPQHOSA-N Alisol b acetate Chemical compound O([C@@H]1[C@@H](OC(C)=O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C NLOAQXKIIGTTRE-JSWHPQHOSA-N 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- DORJGGFFCMZTHW-KXVAGGRESA-N C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O Chemical compound C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O DORJGGFFCMZTHW-KXVAGGRESA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- BUPJOLXWQXEJSQ-UHFFFAOYSA-N Lactifloreol Natural products C=C1CCC(C(C)C)=CC2C(O)(C)CCC21 BUPJOLXWQXEJSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- NLOAQXKIIGTTRE-CXWFPJGHSA-N [1-(3,3-dimethyloxiran-2-yl)-3-[(8s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] acetate Chemical compound C([C@]1(C)[C@@]2(C)CCC3C(C)(C)C(=O)CC[C@]3(C)C2[C@@H](O)CC1=1)CC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-CXWFPJGHSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- MDWXTAJJDBSNKM-KKUMJFAQSA-N alismol Natural products CC(C)C1=CC[C@H]2[C@@H](CC[C@]2(C)O)C(=C)C1 MDWXTAJJDBSNKM-KKUMJFAQSA-N 0.000 description 1
- DORJGGFFCMZTHW-UHFFFAOYSA-N alisol C Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC(=O)C=1C(C)CC(O)C1OC1(C)C DORJGGFFCMZTHW-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036259 sexual stimuli Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000005222 synovial tissue Anatomy 0.000 description 1
- 210000002437 synoviocyte Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗膝关节滑膜炎的中药制剂,其特征在于,选择的中药原料及重量份分别是:丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份。本发明所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有增强免疫力的作用。具有祛风散寒、活血散瘀、消肿止痛的功效,是治疗膝关节滑膜炎的内服纯中草药组成制剂。
Description
技术领域
本发明涉及中药制剂领域,具体涉及一种用于治疗膝关节滑膜炎的中药制剂,具有祛风散寒、活血散瘀、消肿止痛的功效。
背景技术
膝盖滑膜炎又称膝关节滑膜炎,是一种多发性疾病。容易造成患者暂时或长期部分丧失劳动力,对患者危害都较大。膝盖滑膜炎又称膝关节滑膜炎,是一种多发性疾病。容易造成患者暂时或长期部分丧失劳动力,对患者危害都较大。主要是因软骨退变与骨质增生产生的机械性生物化学性刺激,继发膝关节滑膜水肿、渗出和积液等。急性膝盖滑膜炎:外伤包括有:膝关节扭伤、半月板损伤、侧副韧带或交叉韧带损伤,关节内积液或有时积血,表现为急性膝关节外伤性滑膜炎。有时也可因单纯膝关节滑膜损伤所致,如外伤较轻,或长期慢性膝关节劳损。加上风、寒、湿邪侵袭,可使膝关节逐渐出现肿胀和功能障碍者,则形成慢性膝关节滑膜炎。关节肿胀型主要是过度运动后肿胀为主,疼痛轻重不一。非肿胀型,以关节疼痛为主,常伴有轻度肿胀。当膝关节长时间单一动作超量运动之后,滑膜组织充血水肿,红、白细胞及纤维素渗出与关节腔内压升高及氧分压下降呈正相关系,且当渗出速度超过滑膜代偿性吸收速度时,关节积液,进而使关节腔内压继续升高,氧分压继续下降的恶性循环,久之滑膜退变脂肪化生等慢性无菌炎症形成,膝盖滑膜损伤后,滑膜呈现充血、水肿和中性粒细胞浸润。滑膜血管扩张,血浆和细胞外渗,产生大量渗出液,同时滑膜细胞活跃,产生大量粘液素。渗出液中含有红细胞、白细胞、胆红质、脂肪、粘液素和纤维素等。严重者关节积液呈血性。关节肿胀及活动受限。
发明内容:
本发明的目的在于提供一种用于治疗膝关节滑膜炎的中药制剂,具有祛风散寒、活血散瘀、消肿止痛的功效。
为实现上述目的本发明采用了如下的技术方案:本发明所述中药制剂选择的药材及重量份分别是:丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份。
本发明选择的中药原料中:丝瓜络:味甘,性凉。归肺、肝、胃经。体轻通利。通经活络,清热解毒,利尿消肿,止血。主治胸胁胀痛,风湿痹痛,筋脉拘挛,女子经闭,乳汁不通,痰热咳嗽,热毒痈肿,痔漏,水肿,小便不利,便血,崩漏。
女贞子:性味:甘,苦,平。归经:肝;肾经;功效分类:补益药。功效:补益肝肾,清虚热,强腰膝,明耳目,乌须发。主治:头昏目眩;腰膝酸软;遗精;耳鸣;须发早白,骨蒸潮热。
豨签草:性味苦寒,又有化湿热作用,故痹痛偏于湿热的病症尤为适宜。用于中风,半身不遂,腰膝无力等症:本品酒治蒸熟又能强筋骨,适用于四肢麻痹、腰膝无力、中风口眼歪斜、半身不遂等症。用于疮疡肿痛、风疹湿疹瘙痒等症:本品生用还能清热解毒,可用于疮疡肿毒,以及风疹湿疮、皮肤搔痒等症。内服外用均可。此外,本品现在又用于高血压症,有降压作用。
元参:味苦咸。性微寒。无毒。正禀北方水气。兼得春阳之和以生。可升可降。阴也。恶黄、干姜、茴香、山萸。反藜芦。勿犯铜铁。主治:主腹中寒热积聚。女子产乳余疾。补肾气。令人明目。
川牛膝:归经肝;肾经。性味甘;微苦;性平。功能主治:祛风,利湿,通经,活血。治风湿腰膝疼痛,脚痿筋挛,血淋,尿血,妇女经闭,症瘕。用于经闭症瘕,胞衣不下,关节痹痛,足痿筋挛,尿血血淋,跌扑损伤。
防己:功效:利水消肿,祛风止痛。主治:水肿脚气,小便不利,湿疹疮毒,风湿痹痛,高血压症。一般认为,汉防己利水消肿作用较强,木防己祛风止痛作用较好。
薏苡:味甘、淡,性微寒。有健脾利湿、清热排脓功能。用于脾虚泄泻水肿脚气、白带、湿、关节疼痛、肠痈、肺痿等症。尚用于胃癌、子宫颈癌、绒毛膜上皮癌等癌症以及多发性疣。【化学成分】叶含生物碱,种子含有大量淀粉及多种维生素。还含有的主要的主要成分是固醇、多种氨基酸、薏苡仁油、薏苡仁脂、碳水化合物、B族维生素等;【主治】:治胃寒疼痛、气血虚弱。【性味归经】:甘、温脾、胃经。
土茯苓:【功能】解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疗疔疮,痈肿,瘰疬,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。
桂枝:【主治】散寒解表;温通经脉;通阳化气。主风寒表证;寒湿痹痛;四肢厥冷;经闭痛经;症瘕结块;胸痹;心悸;痰饮;小便不利。用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮,水肿,心悸,奔豚。【功效】发汗解肌,温经通脉,助阳化气,散寒止痛。
当归:【化学成分】含基本内酯、正丁烯酰内酯、阿魏酸、烟酸、蔗糖和多种氨基酸,以及倍半萜类化合物等。【性味归经】性温,昧甘、辛。归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
细辛:【归经】:肺经、肾经、心经、肝经、胆经、脾经。【性味】味辛;性温;小毒。【功效】:解表散寒;祛风止痛;温肺化饮;通窍。【主治】:散寒祛风;止痛;温肺化饮;通窍。风寒表证;头痛,牙痛;风湿痹痛;痰饮咳喘;鼻塞;鼻渊;口疮。用于风寒感冒,头痛,牙痛,鼻塞鼻渊,风湿痹痛,痰饮喘咳。
黄芪:具有1、表虚自汗,多用于体虚表弱所致的自汗。2、阴虚盗汗;3、急性肾炎水肿,用于阳气不足所致的虚性水肿;4、慢性肾炎水肿、脾肾虚者;5、阳气虚弱,用于疮疡久不溃破而内陷,有促进溃破及局限作用。6、疮疡久溃不愈,用于疮疡溃破后,久不收口,有生肌收口之作用;7、脾气虚证,虚弱倦怠,泄泻,中气下陷,脏器脱垂,食少纳呆诸症。8、肺气虚证。咳喘日久,气短神疲,痰雍于肺无力咯出。9、多汗而浮肿。10、用于气虚衰弱,倦怠乏力,或中气下陷、脱肛、子宫脱垂。性味:甘,微温。归经:归肺、脾、肝、肾经;有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
白术:【性味归经】苦、甘,温。归脾、胃经。功效:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。
红花:【化学成分】含红花甙、新红花甙、红花醌甙、红花多糖、棕榈酸、肉桂酸、月桂酸。【性味】性温,味辛。【功能主治】活血通经,散淤止痛,用于闭经,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。
泽泻:性味:甘,寒。归经:入肾、膀胱经。功效:利水,渗湿,泄热。治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血。化学成分:块茎含泻醇(alisol)A、B、C、泽泻醇A单乙酸酯(alisol A monoacetate),泽泻醇B单乙酸酯(alisol B monoacetate),泽泻醇C单乙酸醋(alisol Cmonoacetate)表泽泻醇(epialisol)A,泽泻薁醇(alismol),泽泻薁醇氧化物(alismoxide),16β-甲氧基泽泻醇B单乙酸酯(16β-methocyal-isol Bmonoacetate),16β-羟基泽泻醇B单乙酸酯(16β-hydroxyal-isol B monoacetate),谷甾醇-3-O-硬脂酰基-β-D-吡喃葡萄糖甙(sitosterol-3-O-steroyl-β-D-glucopyranoside)。还含胆碱(cho-line),糖和钾、钙、镁等元素。
本发明所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有增强免疫力的作用。具有祛风散寒、活血散瘀、消肿止痛的功效,是治疗膝关节滑膜炎的内服纯中草药组成制剂。临床应用时具有良好的确切效果。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用;为了使该药物的各原料更好地发挥药效,针对某原料药进行特殊提取,如乙醇提取,这些不能用于限制本发明的保护范围。
本发明所述药物具有祛风散寒、活血散瘀、消肿止痛的功效,用于治疗膝关节滑膜炎。本发明人经过反复研究,并通过临床试验的反复验证,终于找到了有更好疗效的内服药物,从而完成了本发明。
临床药效试验材料及典型病例:
1.杜XX,男,52岁。会诊日期2013年1月10日。
患者于2012年1、2月份,因感受寒冷之邪,发现双下肢膝关节疼痛。每遇气候变化时疼痛加重,但局部不红不肿,未做治疗。2012年12月,双膝关节肿胀酸困,屈伸不利,症状加重。在某医院接诊,确诊为关节炎、关节腔积液。口服消炎药治疗半个多月,双膝关节肿胀增剧,积液不断增加,未见明显疗效。故前来就诊。双膝关节肿胀如鹤膝,按之应手,有波动感,以右侧为重。纳呆便溏,下肢冷胀酸困。舌边有齿痕、苔白腻,脉滑数。此为患寒痹日久,加之脾肾亏损,气化不利,水液内停,寒湿凝结,阻滞经络所致。治宜温肾健脾,活血利水。服本方8剂后,肿胀感冷感大减,积液减少,苔白,脉细数。继续服用本方15剂后,双膝关节积液消失,活动自如,病已痊愈。
方法和有效量:丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份;取处方规定量中药材饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
汤剂内服为主,每日早晚2次内服,每次150ml温服。汤剂则作用快而力峻,适应于病情较急重者。如病情较轻或缓者,宜为丸剂内服求其功。
具体实施方式
所述用于治疗膝关节滑膜炎的中药制剂,其特征在于,选择的中药原料及重量份分别是:丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份;
制备方法:取丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份;分别制成饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
Claims (1)
1.用于治疗膝关节滑膜炎的中药制剂,其特征在于,选择的中药原料及重量份分别是:丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份;
其制备方法:取丝瓜络15份、女贞子15份、豨签草15份、元参30份、川牛膝9份、防己24份、薏苡30份、土茯苓30份、桂枝10份、当归20份、细辛3份、黄芪30份、白术12份、红花10份、泽泻12份;分别制成饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410637526.0A CN104398927A (zh) | 2014-10-31 | 2014-10-31 | 治疗膝关节滑膜炎的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410637526.0A CN104398927A (zh) | 2014-10-31 | 2014-10-31 | 治疗膝关节滑膜炎的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104398927A true CN104398927A (zh) | 2015-03-11 |
Family
ID=52636636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410637526.0A Pending CN104398927A (zh) | 2014-10-31 | 2014-10-31 | 治疗膝关节滑膜炎的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104398927A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106798865A (zh) * | 2017-02-16 | 2017-06-06 | 成都市飞龙水处理技术研究所青白江第分所 | 一种治疗急慢性滑膜炎的中药组合物及其制备方法 |
CN108066664A (zh) * | 2018-01-19 | 2018-05-25 | 范鹏程 | 治疗膝关节滑膜炎的中药制剂 |
-
2014
- 2014-10-31 CN CN201410637526.0A patent/CN104398927A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106798865A (zh) * | 2017-02-16 | 2017-06-06 | 成都市飞龙水处理技术研究所青白江第分所 | 一种治疗急慢性滑膜炎的中药组合物及其制备方法 |
CN108066664A (zh) * | 2018-01-19 | 2018-05-25 | 范鹏程 | 治疗膝关节滑膜炎的中药制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103550517B (zh) | 一种治疗肝癌的药物 | |
CN103705894A (zh) | 一种治疗风湿性关节炎的中药汤剂 | |
CN104491831A (zh) | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 | |
CN101129736A (zh) | 治疗更年期综合征的一种中药组合物 | |
CN104721758A (zh) | 一种治疗卵巢囊肿的药物及其制备方法 | |
CN104398927A (zh) | 治疗膝关节滑膜炎的中药制剂 | |
CN101129844A (zh) | 一种治疗更年期综合征的中药组合物 | |
CN101095907A (zh) | 一种治疗糖尿病性末梢神经炎的中成药 | |
CN106692814A (zh) | 一种用于治疗骨病的膏药及其制备方法 | |
CN101130032A (zh) | 一种流产或刮宫后强身健体益气养血的中成药 | |
CN101116710A (zh) | 一种治疗产后小便不通的中药制剂 | |
CN101129884A (zh) | 一种治疗盆腔炎的中成药 | |
CN100571747C (zh) | 一种治疗痛经的中药汤剂 | |
CN105079549A (zh) | 一种治疗狼疮性肾炎的中药 | |
CN104740481A (zh) | 一种治疗功能性子宫出血的中药 | |
CN104225531A (zh) | 一种治疗冠心病的中药 | |
CN103816450B (zh) | 一种治疗类风湿性关节炎的中药 | |
CN103432328B (zh) | 中药熏灸疗法治疗股骨头坏死的中药组合物 | |
CN101129938A (zh) | 治疗输卵管炎的一种中药制剂 | |
CN101574432A (zh) | 治疗腰肌劳损的一种中药制剂 | |
CN101129883A (zh) | 治疗盆腔炎的一种中药组合物 | |
CN104826077A (zh) | 一种用于银屑病膝关节炎中药制剂及其制备方法 | |
CN104127839A (zh) | 一种散阴膏 | |
CN103191211B (zh) | 一种治疗肱骨外上髁炎的中药 | |
CN104383361A (zh) | 治疗急性传染性肝炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150311 |